Colgate-Palmolive Company (NYSE:CL) does about 3.89M shares in volume on a normal day but saw 2463350 shares change hands in Monday trading. The company now has a market cap of 62.86B USD. Its current market price is $75.50, marking an increase of 0.08% compared to the previous close of $75.44. The 52 week high reached by this stock is $84.75 whilst the lowest price level in 52 weeks is $67.84. The script in recent trading has seen the stock touch a high of $75.67 and a low of $74.94.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
Colgate-Palmolive Company (CL) has a 20-day trading average at $78.12 and the current price is -10.91% off the 52-week high compared with 11.29% distance from its 52-week low. The 50-day simple moving average of the closing price is $77.41 and its 200-day simple moving average is $77.23. If we look at the stock’s price movements over the week, volatility stands at 1.72%, which decreases to 1.62% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 39.37 to suggest the stock is neutral.
The consensus objective for the share price is $80.84, suggesting that the stock has a potential upside of 6.61% over the period.
JP Morgan upgraded the stock to “Overweight” from Neutral on October 13, 2022 at a price target of $79. Wells Fargo upgraded its price target at $71-$80.
The current price level is -3.57%, -2.43%, and -2.25% away from its SMA20, SMA50, and SMA200 respectively, with the CL price moving above the 50-day SMA on January 23. Colgate-Palmolive Company (CL) stock is down -3.02% over the week and -2.82% over the past month. Its price is -4.18% year-to-date and -9.35% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/29/2022, with the company’s earnings per share (EPS) of $0.74 above consensus estimates by $0.01. The company’s next earnings report is expected on 04/28/2023, with forecasts estimating quarterly EPS at $0.76 and $2.97 for whole year. CL’s earnings per share are forecast to shrink by -7.50% this year and 7.10% over next year. Expected sales for next quarter are $4.5 billion, which analysts say will come at $17.93 billion for the current fiscal year and next year at $18.48 billion. In addition, estimates put the company’s current quarterly revenue at an average of $4.58 billion.
To reach the target analysts have set, the stock logically needs to grow 6.61 percent from here.
Outstanding shares total 835.70M with insiders holding 0.09% of the shares and institutional holders owning 81.81% of the company’s common stock. The company has a return on investment of 32.90% and return on equity of 448.40%. The price to earnings ratio (P/E ratio) amounts to 32.93 while the forward price to earnings ratio is 23.75. The beta has a value of 0.50. Price to book ratio is 102.03 and price to sales ratio is 3.54.
According to a U.S. Securities and Exchange Commission filing, Vanguard Total Stock Market Index has added its position in Colgate-Palmolive Company (CL) to 25,390,836 shares, mirroring a recent increase by 1.05%. Vanguard Total Stock Market Index added 0.26 million shares of Colgate-Palmolive Company common stock bringing its total worth to about $2.0 billion at the end of recent close, SEC documents show. Vanguard 500 Index Fund raise their holdings by 1.01% in the company over the course of the most recent quarter. It now holds a 2.31% position in Colgate-Palmolive Company thanks to 19.31 million shares amounting to $1.52 billion.
